AGENDA
*All sessions are listed in Eastern Time
LEARNING OBJECTIVES
Upon completion of the educational activity, participants will be able to: [LIST] [ITEM]• Evaluate the most promising updates in MDS therapy [ITEM]• Deliberate on the current and future of JAK inhibitors in MPN treatment paradigms [ITEM]• Employ new agents to design patient-centered treatment plans in AML [ITEM]• Recognize the utility of key clinical trial evidence to ensure improved outcomes in adolescent/adult ALL [ITEM]• Design strategies to integrate practice-changing updates [/LIST]
Day 1: MDS and MPNs
FACULTY
top right
cover
fixed